Back to: Redesigned Pre-Submission Meetings in GDUFA III: Benefits for ANDA Submission and Approval
Presenter
Robert Lionberger, PhD
Director
Office of Research and Standards (ORS)
Office of Generic Drugs (OGD)
Center for Drug Evaluation and Research (CDER)
US Food and Drug Administration (FDA)